Literature DB >> 2658758

Chronic obstructive pulmonary disease: risk factors, pathophysiology and pathogenesis.

G L Snider1.   

Abstract

Chronic obstructive pulmonary disease (COPD) is defined in this chapter, and the relation between its two major components, (a) chronic bronchitis and emphysema and (b) nonremitting asthma, is discussed. Intensity of tobacco smoking and age are the major risk factors for the development of chronic airways obstruction. Environmental air pollution, childhood infections, and familial factors other than alpha-1 protease inhibitor deficiency appear to play only small roles. Emphysema is the major cause of severe airways obstruction; bronchiolitis is a contributing factor and likely is responsible for the minor reversible element of airways obstruction. The elastase-antielastase hypothesis, which is based mainly on indirect evidence, is the best explanation for the pathogenesis of emphysema. Extensive airspace enlargement with fibrosis is infrequently observed; this mechanism may play a role in the pathogenesis of the centrilobular emphysema of smokers.

Entities:  

Mesh:

Year:  1989        PMID: 2658758     DOI: 10.1146/annurev.me.40.020189.002211

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  46 in total

Review 1.  Genetics and pulmonary medicine.10: Genetic epidemiology of pulmonary function.

Authors:  Y Chen
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Involvement of surfactant protein D in emphysema revealed by genetic association study.

Authors:  Takeo Ishii; Koichi Hagiwara; Koichiro Kamio; Shinobu Ikeda; Tomio Arai; Makiko Naka Mieno; Toshio Kumasaka; Masaaki Muramatsu; Motoji Sawabe; Akihiko Gemma; Kozui Kida
Journal:  Eur J Hum Genet       Date:  2011-09-21       Impact factor: 4.246

Review 3.  Guideline-oriented perioperative management of patients with bronchial asthma and chronic obstructive pulmonary disease.

Authors:  Michiaki Yamakage; Sohshi Iwasaki; Akiyoshi Namiki
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

4.  Significant increase of prostaglandin E-major urinary metabolite in male smokers: a screening study of age and gender differences using a simple radioimmunoassay.

Authors:  Isao Okayasu; Hiromitsu Ohnishi; Istvan Sarandi; Junko Shojima; Junko Komatsu; Masae Oritsu; Masataka Sasabe; Kaori Okayasu Nanami; Masaaki Matsuura; Jun-Ichi Azumi; Satoru Ito; Mutsunori Fujiwara
Journal:  J Clin Lab Anal       Date:  2013-12-27       Impact factor: 2.352

5.  Oxidative stress in chronic obstructive pulmonary disease: a lung and systemic process.

Authors:  Stephan F van Eeden; Don D Sin
Journal:  Can Respir J       Date:  2013 Jan-Feb       Impact factor: 2.409

6.  Klotho Reduction in Alveolar Macrophages Contributes to Cigarette Smoke Extract-induced Inflammation in Chronic Obstructive Pulmonary Disease.

Authors:  Lingling Li; Yujie Wang; Wei Gao; Cheng Yuan; Sini Zhang; Hong Zhou; Mao Huang; Xin Yao
Journal:  J Biol Chem       Date:  2015-09-18       Impact factor: 5.157

7.  Elimination of p19ARF-expressing cells enhances pulmonary function in mice.

Authors:  Michihiro Hashimoto; Azusa Asai; Hiroyuki Kawagishi; Ryuta Mikawa; Yuji Iwashita; Kazuki Kanayama; Kazushi Sugimoto; Tadashi Sato; Mitsuo Maruyama; Masataka Sugimoto
Journal:  JCI Insight       Date:  2016-08-04

Review 8.  Oxidative stress and antioxidant defense mechanisms linked to exercise during cardiopulmonary and metabolic disorders.

Authors:  Kelsey Fisher-Wellman; Heather K Bell; Richard J Bloomer
Journal:  Oxid Med Cell Longev       Date:  2009 Jan-Mar       Impact factor: 6.543

Review 9.  Antioxidant therapies in COPD.

Authors:  Irfan Rahman
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

10.  SERPINE2 polymorphisms and chronic obstructive pulmonary disease.

Authors:  Seung Ick Cha; Hyo-Gyoung Kang; Jin Eun Choi; Min Jung Kim; Jaeho Park; Won Kee Lee; Chang Ho Kim; Tae Hoon Jung; Jae Yong Park
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.